DK0883628T3 - 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling - Google Patents

17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling

Info

Publication number
DK0883628T3
DK0883628T3 DK96942491T DK96942491T DK0883628T3 DK 0883628 T3 DK0883628 T3 DK 0883628T3 DK 96942491 T DK96942491 T DK 96942491T DK 96942491 T DK96942491 T DK 96942491T DK 0883628 T3 DK0883628 T3 DK 0883628T3
Authority
DK
Denmark
Prior art keywords
17beta
derivatives
thiode
thioandrosteine
oxo
Prior art date
Application number
DK96942491T
Other languages
English (en)
Inventor
Keith Biggadike
Panayiotis Alexandro Procopiou
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526677.1A external-priority patent/GB9526677D0/en
Priority claimed from GBGB9613120.6A external-priority patent/GB9613120D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0883628T3 publication Critical patent/DK0883628T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96942491T 1995-12-29 1996-12-19 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling DK0883628T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9526677.1A GB9526677D0 (en) 1995-12-29 1995-12-29 Compounds
GBGB9613120.6A GB9613120D0 (en) 1996-06-21 1996-06-21 Compounds
PCT/GB1996/003138 WO1997024368A1 (en) 1995-12-29 1996-12-19 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof

Publications (1)

Publication Number Publication Date
DK0883628T3 true DK0883628T3 (da) 2000-11-06

Family

ID=26308405

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942491T DK0883628T3 (da) 1995-12-29 1996-12-19 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling

Country Status (11)

Country Link
US (1) US6114318A (da)
EP (1) EP0883628B1 (da)
JP (1) JP2951000B2 (da)
AT (1) ATE195529T1 (da)
AU (1) AU1185197A (da)
DE (1) DE69609870T2 (da)
DK (1) DK0883628T3 (da)
ES (1) ES2150149T3 (da)
GR (1) GR3034439T3 (da)
PT (1) PT883628E (da)
WO (1) WO1997024368A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE260931T1 (de) * 1997-06-30 2004-03-15 Glaxo Group Ltd Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
JP3847065B2 (ja) * 2000-08-21 2006-11-15 松下電器産業株式会社 地点登録装置
ITRM20020458A1 (it) * 2002-09-13 2004-03-14 Ambiotec S A S Di Ammendola Sergio Procedimento per la separazione preparativa degli epimeri di steroidi.
AU2010260177A1 (en) 2009-06-16 2011-12-15 Merck Sharp & Dohme Corp. Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481144A (en) * 1984-02-03 1984-11-06 E. R. Squibb & Sons, Inc. 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
ATE154607T1 (de) * 1992-12-24 1997-07-15 Rhone Poulenc Rorer Ltd Neue steroide

Also Published As

Publication number Publication date
WO1997024368A1 (en) 1997-07-10
DE69609870T2 (de) 2001-01-25
JPH11501674A (ja) 1999-02-09
ES2150149T3 (es) 2000-11-16
AU1185197A (en) 1997-07-28
US6114318A (en) 2000-09-05
PT883628E (pt) 2001-01-31
DE69609870D1 (de) 2000-09-21
JP2951000B2 (ja) 1999-09-20
ATE195529T1 (de) 2000-09-15
EP0883628B1 (en) 2000-08-16
GR3034439T3 (en) 2000-12-29
EP0883628A1 (en) 1998-12-16

Similar Documents

Publication Publication Date Title
ATE193883T1 (de) Verbindungen und ihre zusammensetzungen mit entzündungshemmenden und anti-thrombotischen wirkungen
NO962286L (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
AP9801274A0 (en) Lactone derivatives of 17, beta.carboxy, carbothio and amide androstane derivatives.
DE69308029D1 (de) 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOCHINOLINAMINE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS THERAPEUTIKA
DE69523622D1 (de) Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
FI962323A0 (fi) N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit
DK0883628T3 (da) 17beta- (2-oxo-tetrahydrofuran-4-yl) -thioandrostanderivater (17beta- (gamma-smørsyrelacton) -thioderivater) til behandling
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
DK0876393T3 (da) 21-(2-oxo-tetrahydrofuran)-thio-pregnanderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indehold
DE59402079D1 (de) Benzo[f]chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln
NO952926D0 (no) Fremgangsmåte for fremstilling av C-substituerte dietylentriaminer
ES2098119T3 (es) Nuevas triazoloquinazolinas, su obtencion y empleo.
DE69916103D1 (de) 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie